NCT07692022

Brief Summary

This study aims to (1) characterize the multi-domain social cognitive profile and developmental trajectory of children with autism spectrum disorder (ASD) aged 2.5 to 14 years relative to typically developing peers; (2) establish age-referenced normative data for the social cognition assessment battery in a large sample of typically developing children. In the observational component, children with ASD and typically developing controls will undergo a comprehensive assessment battery spanning five domains of social cognition: emotion recognition, theory of mind (ToM), face processing, social communication, and broader social cognitive abilities. Assessments include standardized clinical instruments (ADOS-2, Wechsler intelligence scales), eye-tracking paradigms, and a range of behavioral experimental tasks targeting ToM, empathy, and self-perception. In the normative component, a large sample of typically developing children (target n = 880) will complete the same social cognition assessment battery to establish age-stratified normative reference data. This study is conducted across multiple sites, potentially including international collaborating institutions. Findings will advance the understanding of social cognitive development in ASD and inform the design of scalable, family-implemented interventions.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
30mo left

Started Jan 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jan 2025Dec 2028

Study Start

First participant enrolled

January 5, 2025

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

June 22, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 9, 2026

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2028

Last Updated

July 9, 2026

Status Verified

July 1, 2026

Enrollment Period

4 years

First QC Date

June 22, 2026

Last Update Submit

July 7, 2026

Conditions

Keywords

autismsocial cognition

Outcome Measures

Primary Outcomes (1)

  • Correct on total score of Theory of Mind Task

    Proportion of correct responses on researcher-designed Theory of Mind behavioral experimental tasks

    Baseline

Secondary Outcomes (2)

  • Proportion of Fixation Time on Facial Regions of Interest (%)

    Baseline

  • Age-Stratified Mean Score on Theory of Mind Tasks (TD Normative Sample)

    Baseline

Study Arms (2)

autism

Subjects in the case group are diagnosed with autism spectrum disorder according to DSM-V and clinical observation.

non-autism

Subjects in the control group are healthy children without serious chronic or congenital diseases.

Eligibility Criteria

Age30 Months - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of two groups of children aged 2.5 to 11 years: a clinical group and a typically developing (TD) control group. The clinical group includes children with a confirmed clinical diagnosis of Autism Spectrum Disorder (ASD), validated by a specialist using DSM-5 criteria. The TD control group comprises age-matched individuals with no history of ASD, other neurodevelopmental conditions, or psychiatric disorders. All participants must have an IQ or Developmental Quotient (DQ) equal to or greater than 70, with no co-occurring intellectual disability, and possess normal or corrected-to-normal vision and hearing. Children with known genetic syndromes, severe neurological disorders (e.g., epilepsy, brain injury), or major trauma within the past 3 months are excluded.

You may qualify if:

  • Age between 2 years 6 months and 11 years 11 months, with normative data focusing on 3.0 to 10.0 years.
  • Native Mandarin Chinese speaker, capable of understanding and cooperating with the assessment.
  • Normal development, with no diagnosed neurodevelopmental disorders.
  • Guardian has provided written informed consent.

You may not qualify if:

  • Intellectual/Developmental assessment score (IQ/DQ) less than 70.
  • Diagnosed with Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), language impairment, cerebral palsy, or other neurodevelopmental conditions.
  • Severe hearing or visual impairment that prevents completion of the assessment.
  • History of major psychological or physical trauma within the past 3 months, or significant lack of cooperation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, 201102, China

Location

MeSH Terms

Conditions

Autistic Disorder

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Xiu Xu

    Children's Hospital of Fudan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2026

First Posted

July 9, 2026

Study Start

January 5, 2025

Primary Completion (Estimated)

December 30, 2028

Study Completion (Estimated)

December 30, 2028

Last Updated

July 9, 2026

Record last verified: 2026-07

Locations